Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma

被引:21
|
作者
Cai, Zhiyong [1 ]
He, You'e [2 ]
Yu, Zhengzheng [3 ]
Hu, Jiao [1 ]
Xiao, Zicheng [1 ]
Zu, Xiongbing [1 ]
Li, Zhenghao [4 ,5 ]
Li, Huihuang [1 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Urol, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorder, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Res Ctr Carcinogenesis & Targeted Therapy, Changsha, Peoples R China
[4] Cent South Univ, Hunan Prov Key Lab Hepatobiliary Dis Res, Changsha, Peoples R China
[5] Cent South Univ, Xiangya Hosp 2, Dept Gen Surg, Div Hepatobiliary Pancreat Surg, Changsha, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
cuproptosis; KIRC; tumor microenvironment; immunotherapy; prognosis; CANCER-IMMUNITY; BLOCKADE; SUBTYPE;
D O I
10.3389/fimmu.2022.933241
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundDue to the different infiltration abundance of immune cells in tumor, the efficacy of immunotherapy varies widely among individuals. Recently, growing evidence suggested that cuproptosis has impact on cancer immunity profoundly. However, the comprehensive roles of cuproptosis-related genes in tumor microenvironment (TME) and in response to immunotherapy are still unclear. MethodsBased on 43 cuproptosis-related genes, we employed unsupervised clustering to identify cuproptosis-related patterns and single-sample gene set enrichment analysis algorithm to build a cuproptosis signature for individual patient's immune cell infiltration and efficacy of immune checkpoint blockade (ICB) evaluation. Then, the cuproptosis-related genes were narrowed down using univariate Cox regression model and least absolute shrinkage and selection operator algorithm. Finally, a cuproptosis risk score was built by random survival forest based on these narrowed-down genes. ResultsTwo distinct cuproptosis-related patterns were developed, with cuproptosis cluster 1 showing better prognosis and higher enrichment of immune-related pathways and infiltration of immune cells. For individual evaluation, the cuproptosis signature that we built could be used not only for predicting immune cell infiltration in TME but also for evaluating an individual's sensitivity to ICBs. Patients with higher cuproptosis signature scores exhibited more activated cancer immune processes, higher immune cell infiltration, and better curative efficacy of ICBs. Furthermore, a robust cuproptosis risk score indicated that patients with higher risk scores showed worse survival outcomes, which could be validated in internal and external validation cohorts. Ultimately, a nomogram which combined the risk score with the prognostic clinical factors was developed, and it showed excellent prediction accuracy for survival outcomes. ConclusionDistinct cuproptosis-related patterns have significant differences on prognosis and immune cell infiltration in kidney renal clear cell carcinoma (KIRC). Cuproptosis signature and risk score are able to provide guidance for precision therapy and accurate prognosis prediction for patients with KIRC.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma
    Bian, Zilong
    Fan, Rong
    Xie, Lingmin
    [J]. GENES, 2022, 13 (05)
  • [42] Identification of cuproptosis-related subtypes and characterization of the tumor microenvironment landscape in head and neck squamous cell carcinoma
    Huang, Juntao
    Xu, Ziqian
    Yuan, Zhechen
    Cheng, Lixin
    Zhou, Chongchang
    Shen, Yi
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (09)
  • [43] A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer
    Jiang, Xu
    Ke, Jing
    Jia, Lifeng
    An, Xiang
    Ma, Haiyu
    Li, Zhongwan
    Yuan, Wei
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (01) : 203 - 218
  • [44] A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer
    Xu Jiang
    Jing Ke
    Lifeng Jia
    Xiang An
    Haiyu Ma
    Zhongwan Li
    Wei Yuan
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 203 - 218
  • [45] Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma
    Hong, Peng
    Huang, Weichao
    Du, Huifang
    Hu, Ding
    Cao, Qingfei
    Wang, Yinjie
    Zhang, Huashan
    Tong, Siqiao
    Li, Zizhi
    Tong, Ming
    [J]. FRONTIERS IN GENETICS, 2022, 13
  • [46] Anoikis-related genes signature development for clear cell renal cell carcinoma prognosis and tumor microenvironment
    Yinglei Jiang
    Ying Wang
    Zhengyan Wang
    Yinzhen Zhang
    Yulong Hou
    Xukai Wang
    [J]. Scientific Reports, 13
  • [47] Anoikis-related genes signature development for clear cell renal cell carcinoma prognosis and tumor microenvironment
    Jiang, Yinglei
    Wang, Ying
    Wang, Zhengyan
    Zhang, Yinzhen
    Hou, Yulong
    Wang, Xukai
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [48] Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
    Jiang, Silin
    Dong, Yuxiang
    Wang, Jun
    Zhang, Xi
    Liu, Wei
    Wei, Yong
    Zhou, Hai
    Shen, Luming
    Yang, Jian
    Zhu, Qingyi
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [49] Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma
    Zhang, Dawei
    Ni, Yuanli
    Wang, Yongquan
    Feng, Juan
    Zhuang, Na
    Li, Jiatao
    Liu, Limei
    Shen, Wenhao
    Zheng, Ji
    Zheng, Wei
    Qian, Cheng
    Shan, Juanjuan
    Zhou, Zhansong
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [50] Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma
    Dawei Zhang
    Yuanli Ni
    Yongquan Wang
    Juan Feng
    Na Zhuang
    Jiatao Li
    Limei Liu
    Wenhao Shen
    Ji Zheng
    Wei Zheng
    Cheng Qian
    Juanjuan Shan
    Zhansong Zhou
    [J]. Journal of Translational Medicine, 21